Articles From: Europe stocks in red ahead of U.S. growth data to European Stocks Push Higher

This site contains about 58,903 documents.

View by:

Page: 1 100 200 300 490 500 510 520 530 540 550 560 570 582 583 584 585 586 587 588 589 590 591 592 593 594 595 596 597 598 599 600 601 602 603 604 605 606 607 608 609 610 611 620 630 640 650 660 670 680 690 700 800 900 1,000 1,100 1,200 1,300 1,400 1,500 1,964

2013/4/26

Europe stocks in red ahead of U.S. growth data

LONDON (MarketWatch) — European stock markets were on track to break a five-day winning streak on Friday, with investors staying cautious ahead of a closely watched report on U.S. economic growth in the first quarter.

View more Europe stocks in red ahead of U.S. growth data analysis

Sign-up for Europe stocks in red ahead of U.S. growth data investment picks

2013/5/3

Europe stocks sidelined ahead of U.S. jobs data

MADRID (MarketWatch) — European stock markets stuck to the sidelines on Friday ahead of all-important U.S. jobs data due for release later.

View more Europe stocks sidelined ahead of U.S. jobs data analysis

Sign-up for Europe stocks sidelined ahead of U.S. jobs data investment picks

2013/5/2

Europe stocks still choppy after ECB rate cut

MADRID (MarketWatch) — European stock markets stayed choppy after a European Central Bank rate cut on Thursday, showing muted reaction to the widely expected move.

View more Europe stocks still choppy after ECB rate cut analysis

Sign-up for Europe stocks still choppy after ECB rate cut investment picks

2013/3/7

Europe stocks waver ahead of ECB, BOE meetings

LONDON (MarketWatch) — European stock markets struggled for direction on Thursday, as investors opted to sit on the sidelines ahead of monetary-policy decisions from the European Central Bank and the Bank of England due later in the day.

View more Europe stocks waver ahead of ECB, BOE meetings analysis

Sign-up for Europe stocks waver ahead of ECB, BOE meetings investment picks

2013/3/13

Europe's Largest Analytic Data Event: Teradata Universe Conference from 14 to 17 April

Emphasis on Big Data Analytics and Unified Data Architecture (UDA) Danish author Bjorn Lomborg, Chelsea executive Mike Forde and McKinsey principal Michael Chui among keynote speakers DUSSELDORF, Germany , March 13, 2013 /PRNewswire/ -- Teradata (NYSE: TDC) , the world's leading analytic data solutions company, announced today the 18 th Teradata Universe Conference in Copenhagen , 14 to 17 April.

View more Europe's Largest Analytic Data Event: Teradata Universe Conference from 14 to 17 April analysis

Sign-up for Europe's Largest Analytic Data Event: Teradata Universe Conference from 14 to 17 April investment picks

2013/4/11

Europe's Steel Industry Cites Oversupply, Slow Economy as Greatest Challenges

LONDON , April 11, 2013 /PRNewswire/ -- More than 150 global steel producers, suppliers and end-users identified oversupply and the sluggish global economy as the greatest challenges facing the European steel industry, according to a recent survey conducted by Platts , a leading global energy, petrochemical and metals information provider.

View more Europe's Steel Industry Cites Oversupply, Slow Economy as Greatest Challenges analysis

Sign-up for Europe's Steel Industry Cites Oversupply, Slow Economy as Greatest Challenges investment picks

2013/4/2

European Bankers Expect "Credit Gap" to Shrink for Consumers and Small Businesses, According to FICO-Efma Survey

LONDON , April 2, 2013 /PRNewswire/ -- FICO (NYSE:FICO) , a leading predictive analytics and decision management software company, and Efma today announced the results of the seventh European Credit Risk Survey, which measures retail bankers' outlook for the availability of credit along with their investment priorities for the year ahead.

View more European Bankers Expect "Credit Gap" to Shrink for Consumers and Small Businesses, According to FICO-Efma Survey analysis

Sign-up for European Bankers Expect "Credit Gap" to Shrink for Consumers and Small Businesses, According to FICO-Efma Survey investment picks

2013/4/16

European CDS Spreads Remain Stable Despite Cypriot Banks' Insolvency

LONDON , April 16 2013 /PRNewswire/ -- Western European CDS spreads have experienced a relatively stable quarter, despite receiving news that Cypriot banks - after taking a hit on their investment in Greek bonds - were insolvent, according to S&P Capital IQ's latest quarterly Global Sovereign Debt Credit Risk Report.

View more European CDS Spreads Remain Stable Despite Cypriot Banks' Insolvency analysis

Sign-up for European CDS Spreads Remain Stable Despite Cypriot Banks' Insolvency investment picks

2013/3/8

European Central Bank Decides to Keep Key Rate Unchanged -- Euro Zone's Economy Expected to Experience Growth in 2014

http://media.marketwire.com/attachments/201301/56000_Clipboard01.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=994565&ProfileId=051205&sourceType=1 NEW YORK, NY --

View more European Central Bank Decides to Keep Key Rate Unchanged -- Euro Zone's Economy Expected to Experience Growth in 2014 analysis

Sign-up for European Central Bank Decides to Keep Key Rate Unchanged -- Euro Zone's Economy Expected to Experience Growth in 2014 investment picks

2013/3/22

European CHMP Adopts Positive Opinion for Stribild®, a Once-Daily, Integrase Inhibitor-Based, Single Tablet Regimen for the Treatment of HIV-1 Infection

Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the European Medicines Agency (EMA), has adopted a positive opinion on the company’s Marketing Authorisation Application (MAA) for the once-daily, single tablet regimen Stribild ® for the treatment of HIV-1 infection in adult patients who are antiretroviral-naïve or are infected with HIV-1 without known mutations associated with resistance to any of the three antiretroviral agents in Stribild.

View more European CHMP Adopts Positive Opinion for Stribild®, a Once-Daily, Integrase Inhibitor-Based, Single Tablet Regimen for the Treatment of HIV-1 Infection analysis

Sign-up for European CHMP Adopts Positive Opinion for Stribild®, a Once-Daily, Integrase Inhibitor-Based, Single Tablet Regimen for the Treatment of HIV-1 Infection investment picks

2013/3/25

European Commission Designates MST-188 As An Orphan Medicinal Product

SAN DIEGO , March 25, 2013 /PRNewswire/ -- Mast Therapeutics, Inc. (NYSE MKT: MSTX) today announced that the European Commission (EC) has designated MST-188 as an orphan medicinal product for the treatment of sickle cell disease.

View more European Commission Designates MST-188 As An Orphan Medicinal Product analysis

Sign-up for European Commission Designates MST-188 As An Orphan Medicinal Product investment picks

2013/2/20

European Commission Selects Consortium of Accenture, Morpho and HP to Maintain EU Visa Information and Biometric Matching Systems

The European Commission Directorate General for Home Affairs has awarded a consortium of Accenture (NYSE: ACN) , Morpho (Safran) and HP , a contract to maintain the European Visa Information System ( VIS ). The contract is for three years with a possible one-year extension to a maximum value of €70 million (approx.US$93 million). The project will support the exchange of visa data across border management authorities by ensuring the processing capacity of the system and the availability of high levels of search and matching capabilities required for visa applications.

View more European Commission Selects Consortium of Accenture, Morpho and HP to Maintain EU Visa Information and Biometric Matching Systems analysis

Sign-up for European Commission Selects Consortium of Accenture, Morpho and HP to Maintain EU Visa Information and Biometric Matching Systems investment picks

2013/3/12

European Commission Selects HP to Provide Mission-Critical Servers

http://media.marketwire.com/attachments/201212/109000_36797_HP_Blue_RGB_72_MD.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=995411&ProfileId=051205&sourceType=1 BRUSSELS, BELGIUM --

View more European Commission Selects HP to Provide Mission-Critical Servers analysis

Sign-up for European Commission Selects HP to Provide Mission-Critical Servers investment picks

2013/4/25

European Committee Recommends Against Approval of Pfizer Rheumatoid Arthritis Drug

Pfizer Inc. (PFE) said an advisory committee to European regulators has recommended against the approval of its new rheumatoid arthritis drug, dealing a setback to the drug giant's plans to bring the drug overseas.

View more European Committee Recommends Against Approval of Pfizer Rheumatoid Arthritis Drug analysis

Sign-up for European Committee Recommends Against Approval of Pfizer Rheumatoid Arthritis Drug investment picks

2013/4/26

European Companies Join Forces In Renewable Power-to-Gas Project

AMSTERDAM --Eleven European companies have joined forces to further the development of power-to-gas, a concept to convert electricity to natural gas that could be used to store energy generated from renewable sources.

View more European Companies Join Forces In Renewable Power-to-Gas Project analysis

Sign-up for European Companies Join Forces In Renewable Power-to-Gas Project investment picks

2013/4/29

European educational organizations maximize student and faculty outcomes with Office 365

Education institutions across the region chose the cloud-based productivity suite for improved communication, collaboration and cost benefits.

View more European educational organizations maximize student and faculty outcomes with Office 365 analysis

Sign-up for European educational organizations maximize student and faculty outcomes with Office 365 investment picks

2013/4/8

European Markets Benefit from Japanese Easing

The Bank of Japan's massive stimulus program has spurred Japanese investors on a global search for yield that's reverberating through financial markets.

View more European Markets Benefit from Japanese Easing analysis

Sign-up for European Markets Benefit from Japanese Easing investment picks

2013/05/02

European Markets Little Changed Ahead of ECB

European markets were little changed Thursday ahead of an interest rate decision from the ECB due later in the day.

View more European Markets Little Changed Ahead of ECB analysis

Sign-up for European Markets Little Changed Ahead of ECB investment picks

2013/04/26

European Markets Lower; Snap 5-Day Winning Run

European markets were all lower Friday following a five-day winning run and after some disappointing corporate results added to tame economic data.

View more European Markets Lower; Snap 5-Day Winning Run analysis

Sign-up for European Markets Lower; Snap 5-Day Winning Run investment picks

2013/05/09

European Markets Marginally Lower

European markets were down Thursday tracking losses in Asian markets after higher-than-expected inflation in China raised fears the government would restrict easing measures.

View more European Markets Marginally Lower analysis

Sign-up for European Markets Marginally Lower investment picks

2013/05/07

European Markets Slightly Up

European markets were only slightly higher in early trade Tuesday as the FTSE returned to trading after an extended weekend and with several companies reacting to results announcements.

View more European Markets Slightly Up analysis

Sign-up for European Markets Slightly Up investment picks

2013/05/08

European Markets Slightly Up

European markets were slightly up Wednesday, a day after the German index reached an all-time closing high.

View more European Markets Slightly Up analysis

Sign-up for European Markets Slightly Up investment picks

2013/05/10

European Markets Up; UK Stocks Extend 5-Yr High

European markets were up Friday on the back of gains in Asia where Japanese markets soared after the U.S. dollar climbed to over 100 yen levels for the first time in four years.

View more European Markets Up; UK Stocks Extend 5-Yr High analysis

Sign-up for European Markets Up; UK Stocks Extend 5-Yr High investment picks

2013/3/26

European Medicines Agency accepts marketing authorization application for Boehringer Ingelheim and Eli Lilly and Company's empagliflozin*, an investigational type 2 diabetes treatment

Marketing application for the sodium glucose co-transporter-2 inhibitor follows submission of New Drug Application to U.S. Food and Drug Administration RIDGEFIELD, Conn.

View more European Medicines Agency accepts marketing authorization application for Boehringer Ingelheim and Eli Lilly and Company's empagliflozin*, an investigational type 2 diabetes treatment analysis

Sign-up for European Medicines Agency accepts marketing authorization application for Boehringer Ingelheim and Eli Lilly and Company's empagliflozin*, an investigational type 2 diabetes treatment investment picks

2013/4/9

European Patent Office to Grant VirnetX a Key Patent

Valuable Addition To Growing Portfolio ZEPHYR COVE, Nev.

View more European Patent Office to Grant VirnetX a Key Patent analysis

Sign-up for European Patent Office to Grant VirnetX a Key Patent investment picks

2013/4/23

European Regulators Approve Boeing's Fixes for 787 Batteries

European regulators Tuesday approved Boeing Co.'s (BA) proposal to modify the lithium-ion batteries on its flagship 787 Dreamliner jet, clearing the way for Europe's carriers to fly the wide-bodied jets.

View more European Regulators Approve Boeing's Fixes for 787 Batteries analysis

Sign-up for European Regulators Approve Boeing's Fixes for 787 Batteries investment picks

2013/2/26

European Space Agency Selects Spirent Hybrid Location Technology Solution

Spirent Communications , the leading provider of navigation, positioning and wireless test solutions, today announced that the European Space Agency (ESA) has selected Spirent’s Hybrid Location Technology Solution (HLTS) to expand the location testing capabilities in their R&D labs.

View more European Space Agency Selects Spirent Hybrid Location Technology Solution analysis

Sign-up for European Space Agency Selects Spirent Hybrid Location Technology Solution investment picks

2013/5/6

European Stocks Edge Lower after Downbeat Data

MADRID --European stocks finished marginally lower Monday following gloomy euro-zone economic data.

View more European Stocks Edge Lower after Downbeat Data analysis

Sign-up for European Stocks Edge Lower after Downbeat Data investment picks

2013/04/30

European Stocks Pare Early Gains

European stocks pulled back from early highs Tuesday as investors positioned themselves ahead of key policy announcements later in the week.

View more European Stocks Pare Early Gains analysis

Sign-up for European Stocks Pare Early Gains investment picks

2013/4/2

European Stocks Push Higher

Sara Sjolin and Andrea Tryphonides European stock markets mostly rallied, extending gains from last month, as a news report outlining a potential takeover offer for telecom giant Vodafone Group sparked hopes of more merger activity.

View more European Stocks Push Higher analysis

Sign-up for European Stocks Push Higher investment picks

Start Premium Trial

P	F	Fund Financial Data (13,000+ funds)
P	F	Stock Financial Data (7,000+ stocks)
P	F	Stock and Fund Screeners (basic)
P	F	Investing Articles and Market Commentary
P	F	Articles Archive (>30 days)
P	F	Discuss (dozens of stock, fund, bond, and general bulletin boards)
P	F	Portfolio Manager (basic)
P	F	Morningstar Investment Classroom
P	F	Morningstar Investing Classroom Rewards (earn as you learn and redeem for Morningstar merchandise)
P		Morningstar Fund Analyst Reports (full research on 2,000 funds and ETFs)
P		Morningstar Stock Analyst Reports (full research on 2,000 stocks)
P		Morningstar Stock and Fund Stewardship Grades
P		Portfolio Manager (advanced with 10 x-ray analyses, including guidance)
P		Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P		Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P		Morningstar Stock and Fund Favorites & Red Flags eNewsletters
P		Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P		Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar

Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.

Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.

Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.

Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.

Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.

Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.